Deleting 'irrational' responses from discrete choice experiments: a case of investigating or imposing preferences?

Health Economics
Emily Lancsar, Jordan Louviere

Abstract

Investigation of the 'rationality' of responses to discrete choice experiments (DCEs) has been a theme of research in health economics. Responses have been deleted from DCEs where they have been deemed by researchers to (a) be 'irrational', defined by such studies as failing tests for non-satiation, or (b) represent lexicographic preferences. This paper outlines a number of reasons why deleting responses from DCEs may be inappropriate after first reviewing the theory underpinning rationality, highlighting that the importance placed on rationality depends on the approach to consumer theory to which one ascribes. The aim of this paper is not to suggest that all preferences elicited via DCEs are rational. Instead, it is to suggest a number of reasons why it may not be the case that all preferences labelled as 'irrational' are indeed so. Hence, deleting responses may result in the removal of valid preferences; induce sample selection bias; and reduce the statistical efficiency and power of the estimated choice models. Further, evidence suggests random utility theory may be able to cope with such preferences. Finally, we discuss a number of implications for the design, implementation and interpretation of DCEs and recommend caution ...Continue Reading

References

Sep 1, 1989·Journal of Medical Ethics·G Mooney
Nov 14, 1997·Health Economics·A ShiellJ Seymour
Mar 1, 2000·Health Economics·A ShiellS Cameron
Apr 20, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·G Yaniv
Jan 4, 2001·Health Economics·A ShiellJ Seymour
Mar 26, 2003·Health Economics·Mandy Ryan, Fernando San Miguel
Jan 23, 2004·Health Economics·Michaël SchwarzingerIsabelle Durand-Zaleski
Sep 24, 2004·Health Economics·Fernando San MiguelMabelle Amaya-Amaya
Dec 25, 2004·Health Economics·Mandy Ryan, Mabelle Amaya-Amaya
Aug 1, 2002·Expert Review of Pharmacoeconomics & Outcomes Research·Rosalie VineyJordan Louviere

❮ Previous
Next ❯

Citations

May 6, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Jens Leth HougaardLars Peter Osterdal
Jun 28, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Joachim Marti
Jun 9, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Liv A AugestadIvar Sønbø Kristiansen
Sep 1, 2009·Health Economics, Policy, and Law·Jordan J Louviere, Emily Lancsar
May 13, 2008·Ear and Hearing·Janneke P C GruttersLucien J C Anteunis
Jul 16, 2008·PharmacoEconomics·Emily Lancsar, Jordan Louviere
Aug 28, 2013·Applied Health Economics and Health Policy·J Marjan HummelMaarten J Ijzerman
Mar 16, 2013·Applied Health Economics and Health Policy·Bonny ParkinsonRichard Norman
Jul 10, 2014·PharmacoEconomics·Michael D ClarkEsther W de Bekker-Grob
Nov 19, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Chiara SeghieriSabina Nuti
Jun 13, 2014·PharmacoEconomics·Emily Lancsar, Joffre Swait
Feb 24, 2010·Applied Health Economics and Health Policy·Paul A ScuffhamRuth C Saxby
Dec 27, 2011·Journal of Health Economics·Nick BansbackAslam Anis
Mar 19, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marjon van der PolMandy Ryan
Aug 17, 2010·Vaccine·Esther W de Bekker-GrobIda J Korfage
Aug 18, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L van DamM E van Leerdam
Dec 17, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Heather F BurnettFiona A Miller
Jan 10, 2012·Health Economics·Esther W de Bekker-GrobKaren Gerard
Jun 26, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Rebecca L Hancock-HowardGideon Koren
Jun 14, 2013·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Chris D SkedgelRon L Akehurst
Mar 10, 2009·Health Economics·Semra OzdemirA Brett Hauber
Jul 3, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Christian Pfarr, Andreas Schmid
Dec 3, 2014·Social Science & Medicine·Koonal K ShahAllan J Wailoo
Aug 8, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeshika SinghMartin Buxton
Jan 23, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·F Reed JohnsonJohn F P Bridges
Apr 22, 2016·BMC Medical Research Methodology·Jorien VeldwijkG Ardine de Wit
Jan 23, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Adrienne F G Alayli-GoebbelsJ L Severens
Jul 21, 2014·The Patient·Chris Skedgel, Dean A Regier
Sep 7, 2012·Social Science & Medicine·Benedicte CarlsenOle Frithjof Norheim
Apr 8, 2011·Social Science & Medicine·Begoña Alvarez, Eva Rodríguez-Míguez
Sep 23, 2014·Social Science & Medicine·Gilbert Abotisem AbiiroManuela De Allegri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.